litlas
Log inCreate account

Keith D. Lindor

Active 1979–2024

209
Papers
50,915
Citations
121
h-index
209
i10-index

Citations

Citations per year for Keith D. Lindor1981: 1 citations1982: 3 citations1983: 1 citations1984: 1 citations1985: 1 citations1986: 1 citations1987: 7 citations1988: 1 citations1990: 5 citations1991: 8 citations1992: 5 citations1993: 11 citations1994: 10 citations1995: 27 citations1996: 26 citations1997: 24 citations1998: 25 citations1999: 63 citations2000: 100 citations2001: 116 citations2002: 182 citations2003: 206 citations2004: 277 citations2005: 337 citations2006: 316 citations2007: 358 citations2008: 560 citations2009: 491 citations2010: 551 citations2011: 484 citations2012: 414 citations2013: 610 citations2014: 446 citations2015: 605 citations2016: 436 citations2017: 574 citations2018: 502 citations2019: 1,586 citations2020: 1,479 citations2021: 1,365 citations2022: 1,185 citations2023: 753 citations2024: 1,196 citations2025: 584 citations2026: 34 citations1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,567 citing papers, 24.6% of this breakdownChina: 1,321 citing papers, 9.1% of this breakdownUnited Kingdom: 1,038 citing papers, 7.1% of this breakdownItaly: 965 citing papers, 6.6% of this breakdownGermany: 680 citing papers, 4.7% of this breakdownJapan: 654 citing papers, 4.5% of this breakdownCanada: 482 citing papers, 3.3% of this breakdownFrance: 474 citing papers, 3.3% of this breakdownSpain: 436 citing papers, 3% of this breakdownNetherlands: 404 citing papers, 2.8% of this breakdownSouth Korea: 362 citing papers, 2.5% of this breakdownAustralia: 342 citing papers, 2.4% of this breakdown
0%24.6%Other 26.1%

Institutions

Fields

  • Medicine86.4%
  • Biochemistry, Genetics and Molecular Biology7.4%
  • Pharmacology, Toxicology and Pharmaceutics1.3%
  • Social Sciences0.9%
  • Nursing0.9%
  • Immunology and Microbiology0.8%
  • Other2.3%

Topics

  • Liver Disease Diagnosis and Treatment21%
  • Liver Diseases and Immunity9.3%
  • Liver Disease and Transplantation6%
  • Diet, Metabolism, and Disease4.3%
  • Pediatric Hepatobiliary Diseases and Treatments3.1%
  • Drug Transport and Resistance Mechanisms3%
  • Other53.3%

Coauthors

All papers

Open in search
  1. The NAFLD fibrosis score

    Authors: Paul Angulo, Jason M. Hui, Giulio Marchesini, Ellisabetta Bugianesi, Jacob George, Geoffrey C. Farrell, Felicity Enders, Sushma Saksena, Alastair D. Burt, John P. Bida, Keith D. Lindor, Schuyler O. Sanderson, Marco Lenzi, Leon A. Adams, James G. Kench, Terry M. Therneau, Christopher P. Day - Hepatology 2007 cited by 3,200

  2. A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

    Authors: Frederik Nevens, Pietro Andreoné, G. Mazzella, Simone I. Strasser, Christopher L. Bowlus, Pietro Invernizzi, Joost P.H. Drenth, Paul J. Pockros, Jarosław Reguła, Ulrich Beuers, Michael Trauner, David Jones, Annarosa Floreani, Simon Hohenester, Velimir A. Luketic, Mitchell L. Shiffman, Karel J. van Erpecum, Vı́ctor Vargas, Catherine Vincent, Gideon M. Hirschfield, Hemant Shah, Bettina E. Hansen, Keith D. Lindor, Hanns–Ulrich Marschall, Kris V. Kowdley, Roya Hooshmand-Rad, Tonya Marmon, Shawn Sheeron, Richard Pencek, Leigh MacConell, Mark Pruzanski, Д. А. Шапиро - New England Journal of Medicine 2016 cited by 1,108

  3. Primary Biliary Cholangitis: 2018 Practice Guidance From the American Association for the Study of Liver Diseases

    Authors: Keith D. Lindor, Christopher L. Bowlus, James L. Boyer, Cynthia Levy, Marlyn J. Mayo - Clinical Liver Disease 2018 cited by 883

  4. The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

    Authors: Leon A. Adams, James Lymp, Jenny St. Sauver, Schuyler O. Sanderson, Keith D. Lindor, Ariel E. Feldstein, Paul Angulo - Gastroenterology 2005 cited by 2,896

  5. Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis

    Authors: Giovanni Musso, Roberto Gambino, James H. Tabibian, Mattias Ekstedt, Stergios Kechagias, Masahide Hamaguchi, Rolf Hultcrantz, Hannes Hagström, Seung Kew Yoon, Phunchai Charatcharoenwitthaya, Jacob George, Francisco Barrera, Svanhildur Hafliðadóttir, Einar S. Björnsson, Matthew J. Armstrong, Laurence Hopkins, Xin Gao, Sven Francque, An Verrijken, Yusuf Yılmaz, Keith D. Lindor, Michael Charlton, Robin Haring, Markus M. Lerch, Rainer Rettig, Henry Völzke, Seungho Ryu, Guolin Li, Linda L. Wong, Mariana Verdelho Machado, Helena Cortez‐Pinto, Kohichiroh Yasui, Maurizio Cassader - PLoS Medicine 2014 cited by 723

  6. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

    Authors: Tobias J. Weismüller, Palak Trivedi, Annika Bergquist, Mohamad Imam, Henrike Lenzen, Cyriel Y. Ponsioen, Kristian Holm, Daniel Gotthardt, Martti Färkkilâ, Hanns–Ulrich Marschall, Douglas Thorburn, Rinse K. Weersma, Johan Fevery, Tobias Mueller, Olivier Chazouillères, Kornelius Schulze, Konstantinos N. Lazaridis, Sven Almér, Stephen P. Pereira, Cynthia Levy, Andrew L. Mason, Sigrid Næss, Christopher L. Bowlus, Annarosa Floreani, Emina Halilbasic, Kidist Yimam, Piotr Milkiewicz, Ulrich Beuers, Dep Huynh, Albert Parés, Christine N. Manser, George Ν. Dalekos, Bertus Eksteen, Pietro Invernizzi, Christoph P. Berg, Gabi I. Kirchner, Christoph Sarrazin, Vincent Zimmer, Luca Fabris, Felix Braun, Marco Marzioni, Brian D. Juran, Karouk Said, Christian Rupp, Kalle Jokelainen, M Valle, Francesca Saffioti, Angela Cheung, Michael Trauner, Christoph Schramm, Roger W. Chapman, Tom H. Karlsen, Erik Schrumpf, Christian P. Strassburg, Michael P. Manns, Keith D. Lindor, Gideon M. Hirschfield, Bettina E. Hansen, Kirsten Muri Boberg - Gastroenterology 2017 cited by 523

  7. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

    Authors: Ariel E. Feldstein, Ali Canbay, Paul Angulo, Makiko Taniai, Lawrence J. Burgart, Keith D. Lindor, Gregory J. Gores - Gastroenterology 2003 cited by 1,078

  8. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

    Authors: Zobair M. Younossi, Rohit Loomba, Quentin M. Anstee, Mary E. Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A. Neuschwander‐Tetri, Lawrence Serfaty, Francesco Negro, Stephen H. Caldwell, Vlad Ratziu, Kathleen E. Corey, Scott L. Friedman, Manal F. Abdelmalek, Stephen A. Harrison, Arun J. Sanyal, Joel E. Lavine, Philippe Mathurin, Michael Charlton, Zachary Goodman, Naga P. Chalasani, Kris V. Kowdley, Jacob George, Keith D. Lindor - Hepatology 2017 cited by 427

  9. Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study

    Authors: Willem J. Lammers, Henk R. van Buuren, Gideon M. Hirschfield, Harry L.A. Janssen, Pietro Invernizzi, Andrew L. Mason, Cyriel Y. Ponsioen, Annarosa Floreani, Christophe Corpechot, Marlyn J. Mayo, Pier Maria Battezzati, Albert Parés, Frederik Nevens, Andrew K. Burroughs, Kris V. Kowdley, Palak Trivedi, Teru Kumagi, Angela Cheung, Ana Lleò, Mohamad Imam, Kirsten Boonstra, Nora Cazzagon, I. Franceschet, Raoul Poupon, Llorenç Caballería, Giulia Pieri, Pushpjeet Kanwar, Keith D. Lindor, Bettina E. Hansen - Gastroenterology 2014 cited by 489

  10. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

    Authors: Willem J. Lammers, Gideon M. Hirschfield, Christophe Corpechot, Frederik Nevens, Keith D. Lindor, Harry L.A. Janssen, Annarosa Floreani, Cyriel Y. Ponsioen, Marlyn J. Mayo, Pietro Invernizzi, Pier Maria Battezzati, Albert Parés, Andrew K. Burroughs, Andrew L. Mason, Kris V. Kowdley, Teru Kumagi, Maren H. Harms, Palak Trivedi, Raoul Poupon, Angela Cheung, Ana Lleò, Llorenç Caballería, Bettina E. Hansen, Henk R. van Buuren - Gastroenterology 2015 cited by 436

  11. Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid

    Authors: Gideon M. Hirschfield, Andrew L. Mason, Velimir A. Luketic, Keith D. Lindor, Stuart C. Gordon, Marlyn J. Mayo, Kris V. Kowdley, Catherine Vincent, Henry C. Bodhenheimer, Albert Parés, Michael Trauner, Hanns–Ulrich Marschall, Luciano Adorini, Cathi Sciacca, T. Beecher-Jones, Erin Castelloe, O. Böhm, Д. А. Шапиро - Gastroenterology 2014 cited by 565

  12. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

    Authors: Maren H. Harms, Henk R. van Buuren, Christophe Corpechot, Douglas Thorburn, Harry L.A. Janssen, Keith D. Lindor, Gideon M. Hirschfield, Albert Parés, Annarosa Floreani, Marlyn J. Mayo, Pietro Invernizzi, Pier Maria Battezzati, Frederik Nevens, Cyriel Y. Ponsioen, Andrew L. Mason, Kris V. Kowdley, Willem J. Lammers, Bettina E. Hansen, Adriaan J. van der Meer - Journal of Hepatology 2019 cited by 277

  13. Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls

    Authors: Carla Fiorella Murillo Perez, Holly Fisher, Shaun Hiu, Dorcas Kareithi, Femi Adekunle, Tracy J. Mayne, Elizabeth Smoot Malecha, Erik C. Ness, Adriaan J. van der Meer, Willem J. Lammers, Palak Trivedi, Pier Maria Battezzati, Frederik Nevens, Kris V. Kowdley, Tony Bruns, Nora Cazzagon, Annarosa Floreani, Andrew L. Mason, Albert Parés, María‐Carlota Londoño, Pietro Invernizzi, Marco Carbone, Ana Lleò, Marlyn J. Mayo, George Ν. Dalekos, Nikolaos Gatselis, Douglas Thorburn, Xavier Verhelst, Aliya Gulamhusein, Harry L.A. Janssen, Rachel Smith, Steve Flack, Victoria Mulcahy, Michael Trauner, Christopher L. Bowlus, Keith D. Lindor, Christophe Corpechot, David Jones, George Mells, Gideon M. Hirschfield, James Wason, Bettina E. Hansen, Richard Sturgess, Christopher G. Healey, Anton Gunasekera, Yiannis Kallis, Gavin Wright, Thiriloganathan Mathialahan, Richard J. Evans, Jaber Gasem, David Ramanaden, Emma Ward, Mahesh Bhalme, Paul Southern, James L. Maggs, Mohamed Yousif, George Mells, Brijesh Srivastava, Matthew Foxton, Carole Collins, Yash Prasad, Francisco Porras-Perez, Tom Yapp, Minesh Patel, Roland Ede, Martyn Carte, Konrad Koss, Prayman Sattianayagam, Charles Grimley, Jude Tidbury, Dina Mansour, Matilda Beckley, Coral Hollywood, John Ramag, Harriet Gordon, Joanne Ridpath, Bob Grover, George Abouda, Ian Rees, Mark Narain, Imroz Salam, Paul Banim, Debasish Das, Helen Matthews, Faiyaz Mohammed, Rebecca Jones, Sambit Sen, G. W. G. Bird, Martin Prince, Geeta Prasad, Paul Kitchen, John Hutchinson, Prakash C. Gupta, David Jones, Amir Shah, Subrata Saha, Katharine Pollock, Stephen Barclay, Natasha McDonald, Simon Rushbrook and 56 more - Gastroenterology 2022 cited by 101

  14. Primary biliary cirrhosis

    Authors: Elizabeth J. Carey, Ahmad H. Ali, Keith D. Lindor - The Lancet 2015 cited by 731

  15. Primary sclerosing cholangitis

    Authors: Gideon M. Hirschfield, Tom H. Karlsen, Keith D. Lindor, David Adams - The Lancet 2013 cited by 591

  16. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis #

    Authors: Keith D. Lindor, Kris V. Kowdley, Velimir A. Luketic, Edwyn M Harrison, Timothy M. McCashland, Alex S. Befeler, Denise M. Harnois, Roberta A. Jorgensen, Jan Petz, Jill C. Keach, Jody Mooney, Carol Sargeant, Julie K. Braaten, Tamara Bernard, Debra King, Ellen Miceli, Jeff Schmoll, Tanya L. Hoskin, Prabin Thapa, Felicity Enders - Hepatology 2009 cited by 722

  17. ACG Clinical Guideline: Primary Sclerosing Cholangitis

    Authors: Keith D. Lindor, Kris V. Kowdley, Edwyn M Harrison - The American Journal of Gastroenterology 2015 cited by 531

  18. Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases

    Authors: Keith D. Lindor, Christopher L. Bowlus, James L. Boyer, Cynthia Levy, Marlyn J. Mayo - Hepatology 2021 cited by 129

  19. Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

    Authors: Carla Fiorella Murillo Perez, Maren H. Harms, Keith D. Lindor, Henk R. van Buuren, Gideon M. Hirschfield, Christophe Corpechot, Adriaan J. van der Meer, Jordan J. Feld, Aliya Gulamhusein, Willem J. Lammers, Cyriel Y. Ponsioen, Marco Carbone, Andrew L. Mason, Marlyn J. Mayo, Pietro Invernizzi, Pier Maria Battezzati, Annarosa Floreani, Ana Lleò, Frederik Nevens, Kris V. Kowdley, Tony Bruns, George N. Dalekos, Nikolaos Gatselis, Douglas Thorburn, Palak Trivedi, Xavier Verhelst, Albert Parés, Harry L.A. Janssen, Bettina E. Hansen, on behalf of the GLOBAL PBC Study Group - The American Journal of Gastroenterology 2020 cited by 171

  20. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

    Authors: Zobair M. Younossi, Rohit Loomba, Mary E. Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A. Neuschwander‐Tetri, Lawrence Serfaty, Francesco Negro, Stephen H. Caldwell, Vlad Ratziu, Kathleen E. Corey, Scott L. Friedman, Manal F. Abdelmalek, Stephen A. Harrison, Arun J. Sanyal, Joel E. Lavine, Philippe Mathurin, Michael Charlton, Naga Chalasani, Quentin M. Anstee, Kris V. Kowdley, Jacob George, Zachary Goodman, Keith D. Lindor - Hepatology 2017 cited by 361

  21. Risk Factors and Comorbidities in Primary Biliary Cirrhosis: A Controlled Interview-Based Study of 1032 Patients *

    Authors: Eric M. Gershwin, Carlo Selmi, Howard J. Worman, Ellen B. Gold, Mitchell Watnik, Jessica Utts, Keith D. Lindor, Marshall M. Kaplan, John M. Vierling - Hepatology 2005 cited by 631

  22. Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

    Authors: Carla Perez, Gideon M. Hirschfield, Christophe Corpechot, Annarosa Floreani, Marlyn J. Mayo, Adriaan van der Meer, Cyriel Y. Ponsioen, Willem J. Lammers, Albert Parés, Pietro Invernizzi, Marco Carbone, Pier Maria Battezzati, Frederik Nevens, Kris V. Kowdley, Douglas Thorburn, Andrew L. Mason, Palak Trivedi, Keith D. Lindor, Tony Bruns, George Ν. Dalekos, Nikolaos Gatselis, Xavier Verhelst, Harry L.A. Janssen, Bettina E. Hansen, Aliya Gulamhusein, the GLOBAL PBC Study Group - Alimentary Pharmacology & Therapeutics 2019 cited by 116

  23. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

    Authors: Leon A. Adams, Schuyler O. Sanderson, Keith D. Lindor, Paul Angulo - Journal of Hepatology 2004 cited by 912

  24. Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment

    Authors: Mei Lü, Yueren Zhou, Irina V. Haller, Robert J. Romanelli, Jeffrey J. VanWormer, Carla V. Rodriguez, Heather Anderson, Joseph A. Boscarino, Mark A. Schmidt, Yihe G. Daida, Amandeep Sahota, Jennifer Vincent, Christopher L. Bowlus, Keith D. Lindor, Talan Zhang, Sheri Trudeau, Jia Li, Loralee B. Rupp, Stuart C. Gordon - Clinical Gastroenterology and Hepatology 2017 cited by 135